Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis
Open Access
- 20 May 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 345
Abstract
Esophageal cancer ranks eighth among frequent cancers worldwide. Our aim was to investigate whether and at which neoplastic stage promoter hypermethylation of CAV1 is involved in human esophageal carcinogenesis.Keywords
This publication has 52 references indexed in Scilit:
- Epigenomic program of Barrett's-associated neoplastic progression reveals possible involvement of insulin signaling pathwaysEndocrine-Related Cancer, 2012
- DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's EsophagusAmerican Journal of Gastroenterology, 2009
- A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's EsophagusCancer Research, 2009
- Caveolin-1 in tumor progression: the good, the bad and the uglyCancer and Metastasis Reviews, 2008
- Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesisCancer, 2007
- Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett’s adenocarcinomaGut, 2007
- The multiple faces of caveolaeNature Reviews Molecular Cell Biology, 2007
- A role for caveolae in cell migrationThe FASEB Journal, 2004
- Caveolin-deficient mice: insights into caveolar function human diseaseJournal of Clinical Investigation, 2001
- Sequence and detailed organization of the human caveolin‐1 and ‐2 genes located near the D7S522 locus (7q31.1)FEBS Letters, 1999